Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mebendazole adverse reaction |
Causative agent (attribute) |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Allergy to mebendazole |
Causative agent (attribute) |
False |
Mebendazole (substance) |
Inferred relationship |
Some |
|
Product containing precisely mebendazole 100 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mebendazole (substance) |
Inferred relationship |
Some |
|
Mebendazole 20 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mebendazole (substance) |
Inferred relationship |
Some |
|
Product containing mebendazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Allergy to mebendazole |
Causative agent (attribute) |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing mebendazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mebendazole 100 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mebendazole 100 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Mebendazole 20 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Mebendazole 20 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only mebendazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Mebendazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Mebendazole 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Mebendazole 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Levamisole- and mebendazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
2 |
Levamisole and mebendazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
2 |
Levamisole- and mebendazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
2 |
Product containing only levamisole and mebendazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely levamisole hydrochloride 150 milligram and mebendazole 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levamisole hydrochloride 150 milligram and mebendazole 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mebendazole (substance) |
Inferred relationship |
Some |
1 |